PET and PET/CT in cardiovascular disease

Annals of the New York Academy of Sciences

Volumn 1228, Issue 1, 2011, Pages 109-136

  Gaemperli, Oliver ^a,b   Kaufmann, Philipp A ^b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cardiac sympathetic innervation; Coronary artery disease; Hybrid imaging; Positron emission tomography; Viability

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 6 FLUORO 4 THIA PALMITATE F 18; 6 FLUORODOPAMINE F 18; ACETIC ACID C 11; ADRENALIN C 11; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CARAZOLOL F 18; DIPYRIDAMOLE; ENALAPRIL; FATTY ACID; FLUORO 6 THIA HEPTADECANOIC ACID F 18; FLUORODEOXYGLUCOSE F 18; FLUORODIHYDROROTENONE F 18; FLURPIRIDAZ F 18; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GLUTAMINE; GLYCOGEN; HEXOKINASE; METHYLQUINUCLIDINYL BENZYLATE C 11; NICOTINIC ACID DERIVATIVE; NORADRENALIN; PALMITIC ACID C 11; PARA FLUOROBENZYL TRIPHENYL PHOSPHONIUM F 18; RADIOPHARMACEUTICAL AGENT; RUBIDIUM 82; UNCLASSIFIED DRUG; UNINDEXED DRUG; WATER; YDROXYEPHEDRINE C 11;

ADRENERGIC SYSTEM; AEROBIC METABOLISM; ANGIOCARDIOGRAPHY; APOPTOSIS; ARTICLE; AUTONOMIC DENERVATION; AUTONOMIC INNERVATION; BINDING AFFINITY; CARDIAC IMAGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CELL DEGENERATION; CHRONOTROPISM; CLINICAL PRACTICE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; CYCLOTRON; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ELECTRON; FATTY ACID METABOLISM; FOLLOW UP; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HALF LIFE TIME; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HUMAN; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; INOTROPISM; INTERMETHOD COMPARISON; ISCHEMIC CARDIOMYOPATHY; ISOTOPE LABELING; META ANALYSIS (TOPIC); MOLECULAR IMAGING; MORTALITY; MULTICENTER STUDY (TOPIC); MUSCLE CELL; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHOSPHORYLATION; PHOTON; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; SODIUM RETENTION; TRANSLUMINAL CORONARY ANGIOPLASTY; VASOCONSTRICTION; VASODILATATION; WATER RETENTION;

EID: 79959806287     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06030.x     Document Type: Article

References (207)

1. Ford, E.S., U.A. Ajani, J.B. Croft, et al 2007. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N. Engl. J. Med. 356: 2388-2398.
2. Lloyd-Jones, D., R.J. Adams, T.M. Brown, et al Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: e46-e215.
3. Ter-Pogossian, M.M., M.E. Phelps, E.J. Hoffman & N.A. Mullani 1975. A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology 114: 89-98.
4. Camici, P.G. & F. Crea 2007. Coronary microvascular dysfunction. N. Engl. J. Med. 356: 830-840.
5. Uren, N.G., J.A. Melin, B. De Bruyne, et al 1994. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N. Engl. J. Med. 330: 1782-1788.
6. Camici, P.G., S.K. Prasad & O.E. Rimoldi 2008. Stunning, hibernation, and assessment of myocardial viability. Circulation 117: 103-114.
7. Tillisch, J., R. Brunken, R. Marshall, et al 1986. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N. Engl. J. Med. 314: 884-888.
8. Carrio, I. 2001. Cardiac neurotransmission imaging. J. Nucl. Med. 42: 1062-1076.
9. Klein, C., S.G. Nekolla, F.M. Bengel, et al 2002. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 105: 162-167.
10. Schwitter, J., T. DeMarco, S. Kneifel, et al 2000. Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography. Circulation 101: 2696-2702.
11. Vogel, R., A. Indermuhle, J. Reinhardt, et al 2005. The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J. Am. Coll. Cardiol. 45: 754-762.
12. Sanchez-Crespo, A., P. Andreo & S.A. Larsson 2004. Positron flight in human tissues and its influence on PET image spatial resolution. Eur. J. Nucl. Med. Mol. Imaging 31: 44-51.
13. Nekolla, S.G., S. Reder, A. Saraste, et al 2009. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation 119: 2333-2342.
14. Namdar, M., T.F. Hany, P. Koepfli, et al 2005. Integrated PET/CT for the assessment of coronary artery disease: a feasibility study. J. Nucl. Med. 46: 930-935.
15. Pichler, B.J., H.F. Wehrl & M.S. Judenhofer 2008. Latest advances in molecular imaging instrumentation. J. Nucl. Med. 49(Suppl 2): 5S-23S.
16. Rudd, J.H., F. Hyafil & Z.A. Fayad 2009. Inflammation imaging in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29: 1009-1016.
17. Sanz, J. & Z.A. Fayad 2008. Imaging of atherosclerotic cardiovascular disease. Nature 451: 953-957.
18. 13N-ammonia and 3-dimensional PET. J. Nucl. Med. 48: 1783-1789.
19. 82Rb myocardial perfusion PET imaging. J. Nucl. Med. 44: 1350-1356.
20. Koepfli, P., T.F. Hany, C.A. Wyss, et al 2004. CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner. J. Nucl. Med. 45: 537-542.
21. Schwaiger, M., S.I. Ziegler & S.G. Nekolla PET/CT challenge for the noninvasive diagnosis of coronary artery disease. Eur. J. Radiol. 73: 494-503.
22. Bengel, F.M., T. Higuchi, M.S. Javadi & R. Lautamaki 2009. Cardiac positron emission tomography. J. Am. Coll. Cardiol. 54: 1-15.
23. Kaufmann, P.A., T. Gnecchi-Ruscone, J.T. Yap, et al 1999. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. J. Nucl. Med. 40: 1848-1856.
24. Kaufmann, P.A., T. Gnecchi-Ruscone, M. di Terlizzi, et al 2000. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 102: 1233-1238.
25. Kaufmann, P.A., T. Gnecchi-Ruscone, K.P. Schafers, et al 2000. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J. Am. Coll. Cardiol. 36: 103-109.
26. Gaemperli, O., T. Schepis, P. Koepfli, et al 2008. Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial. J. Am. Coll. Cardiol. 51: 328-329.
27. Pitkanen, O.P., P. Nuutila, O.T. Raitakari, et al 1998. Coronary flow reserve is reduced in young men with IDDM. Diabetes 47: 248-254.
28. Wyss, C.A., P. Koepfli, K. Mikolajczyk, et al 2003. Bicycle exercise stress in PET for assessment of coronary flow reserve: repeatability and comparison with adenosine stress. J. Nucl. Med. 44: 146-154.
29. Schafers, K.P., T.J. Spinks, P.G. Camici, et al 2002. Absolute quantification of myocardial blood flow with H(2)(15)O and 3-dimensional PET: an experimental validation. J. Nucl. Med. 43: 1031-1040.
30. 15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres. Circulation 87: 512-525.
31. Bergmann, S.R., K.A. Fox, A.L. Rand, et al 1984. Quantification of regional myocardial blood flow in vivo with H215O. Circulation 70: 724-733.
32. Adachi, I., O. Gaemperli, I. Valenta, et al 2007. Assessment of myocardial perfusion by dynamic O-15-labeled water PET imaging: validation of a new fast factor analysis. J. Nucl. Cardiol. 14: 698-705.
33. Hermansen, F., J. Ashburner, T.J. Spinks, et al 1998. Generation of myocardial factor images directly from the dynamic oxygen-15-water scan without use of an oxygen-15-carbon monoxide blood-pool scan. J. Nucl. Med. 39: 1696-1702.
34. Araujo, L.I., A.A. Lammertsma, C.G. Rhodes, et al 1991. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 83: 875-885.
35. Muzik, O., R.S. Beanlands, G.D. Hutchins, et al 1993. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J. Nucl. Med. 34: 83-91.
36. Bellina, C.R., O. Parodi, P. Camici, et al 1990. Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow. J. Nucl. Med. 31: 1335-1343.
37. 13N-ammonia and PET: comparison of tracer models. J. Nucl. Med. 40: 1045-1055.
38. Rauch, B., F. Helus, M. Grunze, et al 1985. Kinetics of 13N-ammonia uptake in myocardial single cells indicating potential limitations in its applicability as a marker of myocardial blood flow. Circulation 71: 387-393.
39. Schelbert, H.R., M.E. Phelps, E.J. Hoffman, et al 1979. Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am. J. Cardiol. 43: 209-218.
40. 15O]water techniques. Circulation 93: 2000-2006.
41. Herzog, B.A., L. Husmann, I. Valenta, et al 2009. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J. Am. Coll. Cardiol. 54: 150-156.
42. Koepfli, P., C.A. Wyss, M. Namdar, et al 2004. Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: differential effects in stenotic versus remote myocardial segments. J. Nucl. Med. 45: 1626-1631.
43. Cecchi, F., I. Olivotto, R. Gistri, et al 2003. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N. Engl. J. Med. 349: 1027-1035.
44. Neglia, D., C. Michelassi, M.G. Trivieri, et al 2002. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 105: 186-193.
45. Lautamaki, R., R.T. George, K. Kitagawa, et al 2009. Rubidium-82 PET-CT for quantitative assessment of myocardial blood flow: validation in a canine model of coronary artery stenosis. Eur. J. Nucl. Med. Mol. Imaging 36: 576-586.
46. Herrero, P., J. Markham, M.E. Shelton, et al 1990. Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model. Circulation 82: 1377-1386.
47. Goldstein, R.A., N.A. Mullani, S.K. Marani, et al 1983. Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic interventions. J. Nucl. Med. 24: 907-915.
48. Herrero, P., J.J. Hartman, M.A. Green, et al 1996. Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET. J. Nucl. Med. 37: 1294-1300.
49. Studenov, A.R. & M.S. Berridge 2001. Synthesis and properties of 18F-labeled potential myocardial blood flow tracers. Nucl. Med. Biol. 28: 683-693.
50. Kim, S.W., S.D. Yang, B.J. Ahn, et al 2005. In vivo targeting of ERG potassium channels in mice and dogs by a positron-emitting analogue of fluoroclofilium. Exp. Mol. Med. 37: 269-275.
51. Madar, I., H.T. Ravert, Y. Du, et al 2006. Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J. Nucl. Med. 47: 1359-1366.
52. Marshall, R.C., P. Powers-Risius, B.W. Reutter, et al 2004. Kinetic analysis of 18F-fluorodihydrorotenone as a deposited myocardial flow tracer: comparison to 201Tl. J. Nucl. Med. 45: 1950-1959.
53. Huisman, M.C., T. Higuchi, S. Reder, et al 2008. Initial characterization of an 18F-labeled myocardial perfusion tracer. J. Nucl. Med. 49: 630-636.
54. Schinkel, A.F., J.J. Bax, D. Poldermans, et al 2007. Hibernating myocardium: diagnosis and patient outcomes. Curr. Probl. Cardiol. 32: 375-410.
55. Beanlands, R.S., G. Nichol, E. Huszti, et al 2007. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J. Am. Coll. Cardiol. 50: 2002-2012.
56. Camici, P., E. Ferrannini & L.H. Opie 1989. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog. Cardiovasc. Dis. 32: 217-238.
57. Wijns, W., S.F. Vatner & P.G. Camici 1998. Hibernating myocardium. N. Engl. J. Med. 339: 173-181.
58. Gropler, R.J., B.A. Siegel, K.J. Lee, et al 1990. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J. Nucl. Med. 31: 1749-1756.
59. Knuuti, J., H.R. Schelbert & J.J. Bax 2002. The need for standardisation of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction. Eur. J. Nucl. Med. Mol. Imaging 29: 1257-1266.
60. 18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J. Nucl. Med. 19: 1311-1319.
61. Dilsizian, V., S.L. Bacharach, R.S. Beanlands, et al 2009. ASNC imaging guidelines for nuclear cardiology procedures. PET myocardial perfusion and metabolism clinical imaging. Available at Accessed April 21, 2011.
62. Wichter, T., M. Schafers, C.G. Rhodes, et al 2000. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. Circulation 101: 1552-1558.
63. Schafers, M., H. Lerch, T. Wichter, et al 1998. Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. J. Am. Coll. Cardiol. 32: 181-186.
64. Momose, M., L. Tyndale-Hines, F.M. Bengel & M. Schwaiger 2001. How heterogeneous is the cardiac autonomic innervation? Basic Res. Cardiol. 96: 539-546.
65. Schafers, M., D. Dutka, C.G. Rhodes, et al 1998. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ. Res. 82: 57-62.
66. Mardon, K., O. Montagne, N. Elbaz, et al 2003. Uptake-1 carrier downregulates in parallel with the beta-adrenergic receptor desensitization in rat hearts chronically exposed to high levels of circulating norepinephrine: implications for cardiac neuroimaging in human cardiomyopathies. J. Nucl. Med. 44: 1459-1466.
67. Di Carli, M.F., M.C. Tobes, T. Mangner, et al 1997. Effects of cardiac sympathetic innervation on coronary blood flow. N. Engl. J. Med. 336: 1208-1215.
68. Bengel, F.M., P. Ueberfuhr, S.I. Ziegler, et al 1999. Serial assessment of sympathetic reinnervation after orthotopic heart transplantation. A longitudinal study using PET and C-11 hydroxyephedrine. Circulation 99: 1866-1871.
69. Munch, G., N.T. Nguyen, S. Nekolla, et al 2000. Evaluation of sympathetic nerve terminals with [(11)C]epinephrine and [(11)C]hydroxyephedrine and positron emission tomography. Circulation 101: 516-523.
70. Sambuceti, G. 2005. Differences and similarities between coronary atherosclerosis and ischaemic heart disease: implications for cardiac imaging. Eur. J. Nucl. Med. Mol. Imaging 32: 385-388.
71. Gould, K.L., R.A. Goldstein, N.A. Mullani, et al 1986. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82. J. Am. Coll. Cardiol. 7: 775-789.
72. Demer, L.L., K.L. Gould, R.A. Goldstein, et al 1989. Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients. Circulation 79: 825-835.
73. Go, R.T., T.H. Marwick, W.J. MacIntyre, et al 1990. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J. Nucl. Med. 31: 1899-1905.
74. Schelbert, H.R., G. Wisenberg, M.E. Phelps, et al 1982. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography. Am. J. Cardiol. 49: 1197-1207.
75. 13N-ammonia and high-resolution positron-emission computed tomography. Am. Heart J. 113: 645-654.
76. Stewart, R.E., M. Schwaiger, E. Molina, et al 1991. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am. J. Cardiol. 67: 1303-1310.
77. Tamaki, N., Y. Yonekura, M. Senda, et al 1988. Value and limitation of stress thallium-201 single photon emission computed tomography: comparison with nitrogen-13 ammonia positron tomography. J. Nucl. Med. 29: 1181-1188.
78. Sampson, U.K., S. Dorbala, A. Limaye, et al 2007. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J. Am. Coll. Cardiol. 49: 1052-1058.
79. Bateman, T.M., G.V. Heller, A.I. McGhie, et al 2006. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J. Nucl. Cardiol. 13: 24-33.
80. Marwick, T.H., J.J. Nemec, W.J. Stewart & E.E. Salcedo 1992. Diagnosis of coronary artery disease using exercise echocardiography and positron emission tomography: comparison and analysis of discrepant results. J. Am. Soc. Echocardiogr. 5: 231-238.
81. Grover-McKay, M., O. Ratib, M. Schwaiger, et al 1992. Detection of coronary artery disease with positron emission tomography and rubidium 82. Am. Heart J. 123: 646-652.
82. Klocke, F.J., M.G. Baird, B.H. Lorell, et al 2003. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J. Am. Coll. Cardiol. 42: 1318-1333.
83. Machac, J. 2005. Cardiac positron emission tomography imaging. Semin. Nucl. Med. 35: 17-36.
84. Di Carli, M.F. & R. Hachamovitch 2007. New technology for noninvasive evaluation of coronary artery disease. Circulation 115: 1464-1480.
85. Iskander, S. & A.E. Iskandrian 1998. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J. Am. Coll. Cardiol. 32: 57-62.
86. Hachamovitch, R., S.W. Hayes, J.D. Friedman, et al 2003. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107: 2900-2907.
87. Marwick, T.H., K. Shan, S. Patel, et al 1997. Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease. Am. J. Cardiol. 80: 865-870.
88. Yoshinaga, K., B.J. Chow, K. Williams, et al 2006. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J. Am. Coll. Cardiol. 48: 1029-1039.
89. Schenker, M.P., S. Dorbala, E.C. Hong, et al 2008. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation 117: 1693-1700.
90. Lertsburapa, K., A.W. Ahlberg, T.M. Bateman, et al 2008. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J. Nucl. Cardiol. 15: 745-753.
91. Dorbala, S., R. Hachamovitch, Z. Curillova, et al 2009. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc. Imaging 2: 846-854.
92. Kaufmann, P.A. & P.G. Camici 2005. Myocardial blood flow measurement by PET: technical aspects and clinical applications. J. Nucl. Med. 46: 75-88.
93. Camici, P.G., O.E. Rimoldi 2009. The clinical value of myocardial blood flow measurement. J. Nucl. Med. 50: 1076-1087.
94. Dayanikli, F., D. Grambow, O. Muzik, et al 1994. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 90: 808-817.
95. Guethlin, M., A.M. Kasel, K. Coppenrath, et al 1999. Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin. Circulation 99: 475-481.
96. Yokoyama, I., T. Ohtake, S. Momomura, et al 1996. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation 94: 3232-3238.
97. Yokoyama, I., T. Murakami, T. Ohtake, et al 1996. Reduced coronary flow reserve in familial hypercholesterolemia. J. Nucl. Med. 37: 1937-1942.
98. Gimelli, A., J. Schneider-Eicke, D. Neglia, et al 1998. Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy. J. Am. Coll. Cardiol. 31: 366-373.
99. Di Carli, M.F., J. Janisse, G. Grunberger & J. Ager 2003. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J. Am. Coll. Cardiol. 41: 1387-1393.
100. Yokoyama, I., S. Momomura, T. Ohtake, et al 1997. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 30: 1472-1477.
101. Campisi, R., J. Czernin, H. Schoder, et al 1999. L-Arginine normalizes coronary vasomotion in long-term smokers. Circulation 99: 491-497.
102. Lorenzoni, R., S.D. Rosen & P.G. Camici 1996. Effect of alpha 1-adrenoceptor blockade on resting and hyperemic myocardial blood flow in normal humans. Am. J. Physiol. 271: H1302-H1306.
103. Bottcher, M., J. Czernin, K. Sun, et al 1997. Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. J. Nucl. Med. 38: 442-446.
104. Gould, K.L., J.P. Martucci, D.I. Goldberg, et al 1994. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. Circulation 89: 1530-1538.
105. Czernin, J., R.J. Barnard, K.T. Sun, et al 1995. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation 92: 197-204.
106. Walsh, M.N., E.M. Geltman, R.L. Steele, et al 1990. Augmented myocardial perfusion reserve after coronary angioplasty quantified by positron emission tomography with H2(15)O. J. Am. Coll. Cardiol. 15: 119-127.
107. Uren, N.G., T. Crake, D.C. Lefroy, et al 1993. Delayed recovery of coronary resistive vessel function after coronary angioplasty. J. Am. Coll. Cardiol. 21: 612-621.
108. Di Carli, M., J. Czernin, C.K. Hoh, et al 1995. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 91: 1944-1951.
109. 82Rb PET imaging and coronary artery stenosis severity. Eur. J. Nucl. Med. Mol. Imaging 35: 1593-1601.
110. Knuuti, J. 2009. Integrated positron emission tomography/computed tomography (PET/CT) in coronary disease. Heart 95: 1457-1463.
111. Ragosta, M., A.H. Bishop, L.C. Lipson, et al 2007. Comparison between angiography and fractional flow reserve versus single-photon emission computed tomographic myocardial perfusion imaging for determining lesion significance in patients with multivessel coronary disease. Am. J. Cardiol. 99: 896-902.
112. 82Rb PET/CT study. J. Nucl. Med. 48: 349-358.
113. Emond, M., M.B. Mock, K.B. Davis, et al 1994. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 90: 2645-2657.
114. Yoshinaga, K., C. Katoh, K. Noriyasu, et al 2003. Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: a study using oxygen 15-labeled water PET. J. Nucl. Cardiol. 10: 275-283.
115. Parkash, R., R.A. deKemp, T.D. Ruddy, et al 2004. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease. J. Nucl. Cardiol. 11: 440-449.
116. Schindler, T.H., E.U. Nitzsche, H.R. Schelbert, et al 2005. Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J. Am. Coll. Cardiol. 45: 1505-1512.
117. Tio, R.A., A. Dabeshlim, H.M. Siebelink, et al 2009. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J. Nucl. Med. 50: 214-219.
118. Chareonthaitawee, P., B.J. Gersh, P.A. Araoz & R.J. Gibbons 2005. Revascularization in severe left ventricular dysfunction: the role of viability testing. J. Am. Coll. Cardiol. 46: 567-574.
119. Chatterjee, K., H.J. Swan, W.W. Parmley, et al 1973. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction. Circulation 47: 276-286.
120. Horn, H.R., L.E. Teichholz, P.F. Cohn, et al 1974. Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine. The epinephrine ventriculogram. Circulation 49: 1063-1071.
121. Heyndrickx, G.R., R.W. Millard, R.J. McRitchie, et al 1975. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J. Clin. Invest. 56: 978-985.
122. Barnes, E., D.P. Dutka, M. Khan, et al 2002. Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans. Am. J. Physiol. Heart Circ. Physiol. 282: H1603-H1608.
123. Diamond, G.A., J.S. Forrester, P.L. deLuz, et al 1978. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am. Heart J. 95: 204-209.
124. Rahimtoola, S.H. 1985. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 72: V123-V135.
125. Rahimtoola, S.H. 1989. The hibernating myocardium. Am. Heart J. 117: 211-221.
126. Pagano, D., F. Fath-Ordoubadi, K.J. Beatt, et al 2001. Effects of coronary revascularisation on myocardial blood flow and coronary vasodilator reserve in hibernating myocardium. Heart 85: 208-212.
127. Underwood, S.R., J.J. Bax, J. vom Dahl, et al 2004. Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur. Heart J. 25: 815-836.
128. Bax, J.J., F.C. Visser, D. Poldermans, et al 2001. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation 104: I314-I318.
129. Pagano, D., J.N. Townend, D.V. Parums, et al 2000. Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake. Heart 83: 456-461.
130. Knuesel, P.R., D. Nanz, C. Wyss, et al 2003. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. Circulation 108: 1095-1100.
131. Di Carli, M.F. & M.J. Lipton, editors. 2007. Cardiac PET and PET/CT Imaging, Springer Science and Business Media, New York.
132. 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/18F-FDG PET. Eur. J. Nucl. Med. Mol. Imaging 33: 716-723.
133. Wiggers, H., H. Egeblad, T.T. Nielsen & H.E. Botker 2001. Prediction of reversible myocardial dysfunction by positron emission tomography, low-dose dobutamine echocardiography, resting ECG, and exercise testing. Cardiology 96: 32-37.
134. Gerber, B.L., F.F. Ordoubadi, W. Wijns, et al 2001. Positron emission tomography using (18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of (18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability. Eur. Heart J. 22: 1691-1701.
135. Bax, J.J., J. Maddahi, D. Poldermans, et al 2003. Preoperative comparison of different noninvasive strategies for predicting improvement in left ventricular function after coronary artery bypass grafting. Am. J. Cardiol. 92: 1-4.
136. Bax, J.J., F.C. Visser, D. Poldermans, et al 2001. Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J. Nucl. Med. 42: 79-86.
137. Marwick, T.H., J.J. Nemec, A. Lafont, et al 1992. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am. J. Cardiol. 69: 854-859.
138. Marwick, T.H., C. Zuchowski, M.S. Lauer, et al 1999. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J. Am. Coll. Cardiol. 33: 750-758.
139. Di Carli, M.F., F. Asgarzadie, H.R. Schelbert, et al 1995. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 92: 3436-3444.
140. vom Dahl, J., C. Altehoefer, F.H. Sheehan, et al 1997. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. J. Nucl. Med. 38: 742-748.
141. Yoshida, K. & K.L. Gould 1993. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J. Am. Coll. Cardiol. 22: 984-997.
142. Haas, F., C.J. Haehnel, W. Picker, et al 1997. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J. Am. Coll. Cardiol. 30: 1693-1700.
143. Zhang, X., X.J. Liu, Q. Wu, et al 2001. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET. J. Nucl. Med. 42: 1166-1173.
144. Eitzman, D., Z. al-Aouar, H.L. Kanter, et al 1992. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J. Am. Coll. Cardiol. 20: 559-565.
145. Di Carli, M.F., M. Davidson, R. Little, et al 1994. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am. J. Cardiol. 73: 527-533.
146. Lee, K.S., T.H. Marwick, S.A. Cook, et al 1994. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 90: 2687-2694.
147. Di Carli, M.F., J. Maddahi, S. Rokhsar, et al 1998. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J. Thorac. Cardiovasc. Surg. 116: 997-1004.
148. Pagano, D., M.E. Lewis, J.N. Townend, et al 1999. Coronary revascularisation for postischaemic heart failure: how myocardial viability affects survival. Heart 82: 684-688.
149. Desideri, A., L. Cortigiani, A.I. Christen, et al 2005. The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction. J. Am. Coll. Cardiol. 46: 1264-1269.
150. D'Egidio, G., G. Nichol, K.A. Williams, et al 2009. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc. Imaging. 2: 1060-1068.
151. Inaba, Y., J.A. Chen & S.R. Bergmann Quantity of viable myocardium required to improve survival with revascularization in patients with ischemic cardiomyopathy: a meta-analysis. J. Nucl. Cardiol. 17: 646-654.
152. Velazquez, E.J., K.L. Lee, C.M. O'Connor, et al 2007. The rationale and design of the surgical treatment for ischemic heart failure (STICH) trial. J. Thorac. Cardiovasc. Surg. 134: 1540-1547.
153. Siebelink, H.M., P.K. Blanksma, H.J. Crijns, et al 2001. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J. Am. Coll. Cardiol. 37: 81-88.
154. Beanlands, R.S., P.J. Hendry, R.G. Masters, et al 1998. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 98: II51-II56.
155. Bristow, M.R., W. Minobe, R. Rasmussen, et al 1992. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J. Clin. Invest. 89: 803-815.
156. Fowler, M.B., J.A. Laser, G.L. Hopkins, et al 1986. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 74: 1290-1302.
157. Pagani, M., F. Lombardi, S. Guzzetti, et al 1986. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ. Res. 59: 178-193.
158. Grassi, G., G. Seravalle, B.M. Cattaneo, et al 1995. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 92: 3206-3211.
159. Rundqvist, B., R. Casale, Y. Bergmann-Sverrisdottir, et al 1997. Rapid fall in sympathetic nerve hyperactivity in patients with heart failure after cardiac transplantation. J. Card. Fail. 3: 21-26.
160. Bengel, F.M., P. Ueberfuhr, N. Schiepel, et al 2001. Effect of sympathetic reinnervation on cardiac performance after heart transplantation. N. Engl. J. Med. 345: 731-738.
161. Triposkiadis, F., G. Karayannis, G. Giamouzis, et al 2009. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J. Am. Coll. Cardiol. 54: 1747-1762.
162. Floras, J.S. 2009. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J. Am. Coll. Cardiol. 54: 375-385.
163. Mann, D.L., R.L. Kent, B. Parsons & G.T. Cooper 1992. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85: 790-804.
164. Zaugg, M., W. Xu, E. Lucchinetti, et al 2000. Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 102: 344-350.
165. Merlet, P., H. Valette, J.L. Dubois-Rande, et al 1992. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J. Nucl. Med. 33: 471-477.
166. Merlet, P., C. Benvenuti, D. Moyse, et al 1999. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J. Nucl. Med. 40: 917-923.
167. Momose, M., H. Kobayashi, N. Iguchi, et al 1999. Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy. Nucl. Med. Commun. 20: 529-535.
168. Somsen, G.A., J.J. Borm, P.A. de Milliano, et al 1995. Quantitation of myocardial iodine-123 MIBG uptake in SPET studies: a new approach using the left ventricular cavity and a blood sample as a reference. Eur. J. Nucl. Med. 22: 1149-1154.
169. Spyrou, N., S.D. Rosen, F. Fath-Ordoubadi, et al 2002. Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. J. Am. Coll. Cardiol. 40: 1216-1224.
170. Gaemperli, O., R. Liga, N. Spyrou, et al Myocardial {beta}-adrenoceptor down-regulation early after infarction is associated with long-term incidence of congestive heart failure. Eur. Heart J. 31: 1722-1729.
171. Agostini, D., H.J. Verberne, W. Burchert, et al 2008. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur. J. Nucl. Med. Mol. Imaging 35: 535-546.
172. Jacobson, A.F., R. Senior, M.D. Cerqueira, et al 2010. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J. Am. Coll. Cardiol. 55: 2212-2221.
173. Stein, P.D., A.Y. Yaekoub, F. Matta & H.D. Sostman 2008. 64-slice CT for diagnosis of coronary artery disease: a systematic review. Am. J. Med. 121: 715-725.
174. Gaemperli, O., T. Schepis, V. Kalff, et al 2007. Validation of a new cardiac image fusion software for three-dimensional integration of myocardial perfusion SPECT and stand-alone 64-slice CT angiography. Eur. J. Nucl. Med. Mol. Imaging 34: 1097-1106.
175. Kaufmann, P.A. & O. Gaemperli 2009. Combining CT and nuclear: a winning hybrid team. J. Nucl. Cardiol. 16: 170-172.
176. Schindler, T.H, N. Magosaki, M. Jeserich, et al 1999. Fusion imaging: combined visualization of 3D reconstructed coronary artery tree and 3D myocardial scintigraphic image in coronary artery disease. Int. J. Card. Imaging 15: 357-368; discussion 369-370.
177. Javadi, M.S., R. Lautamaki, J. Merrill, et al Definition of vascular territories on myocardial perfusion images by integration with true coronary anatomy: a hybrid PET/CT analysis. J. Nucl. Med. 51: 198-203.
178. Di Carli, M.F., S. Dorbala, Z. Curillova, et al 2007. Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J. Nucl. Cardiol. 14: 799-809.
179. Schuijf, J.D., W. Wijns, J.W. Jukema, et al 2006. Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging. J. Am. Coll. Cardiol. 48: 2508-2514.
180. Rispler, S., Z. Keidar, E. Ghersin, et al 2007. Integrated single-photon emission computed tomography and computed tomography coronary angiography for the assessment of hemodynamically significant coronary artery lesions. J. Am. Coll. Cardiol. 49: 1059-1067.
181. Gaemperli, O., T. Schepis, I. Valenta, et al 2007. Cardiac image fusion from stand-alone SPECT and CT: clinical experience. J. Nucl. Med. 48: 696-703.
182. Santana, C.A., E.V. Garcia, T.L. Faber, et al 2009. Diagnostic performance of fusion of myocardial perfusion imaging (MPI) and computed tomography coronary angiography. J. Nucl. Cardiol. 16: 201-211.
183. Slomka, P.J., V.Y. Cheng, D. Dey, et al 2009. Quantitative analysis of myocardial perfusion SPECT anatomically guided by coregistered 64-slice coronary CT angiography. J. Nucl. Med. 50: 1621-1630.
184. Gaemperli, O., L. Husmann, T. Schepis, et al 2009. Coronary CT angiography and myocardial perfusion imaging to detect flow-limiting stenoses: a potential gatekeeper for coronary revascularization? Eur. Heart J. 30: 2921-2929.
185. Husmann, L., I. Valenta, O. Gaemperli, et al 2008. Feasibility of low-dose coronary CT angiography: first experience with prospective ECG-gating. Eur. Heart J. 29: 191-197.
186. Agatston, A.S., W.R. Janowitz, F.J. Hildner, et al 1990. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15: 827-832.
187. Rumberger, J.A., D.B. Simons, L.A. Fitzpatrick, et al 1995. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 92: 2157-2162.
188. Greenland, P., R.O. Bonow, B.H. Brundage, et al 2007. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation 115: 402-426.
189. van Werkhoven, J.M., J.D. Schuijf, O. Gaemperli, et al 2009. Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease. J. Am. Coll. Cardiol. 53: 623-632.
190. Wu, J.C., F.M. Bengel & S.S. Gambhir 2007. Cardiovascular molecular imaging. Radiology 244: 337-355.
191. Knuuti, J. & F.M. Bengel 2008. Positron emission tomography and molecular imaging. Heart 94: 360-367.
192. 18F]-fluorodeoxyglucose positron emission tomography. Circulation 105: 2708-2711.
193. Langer, H.F., R. Haubner, B.J. Pichler & M. Gawaz 2008. Radionuclide imaging: a molecular key to the atherosclerotic plaque. J. Am. Coll. Cardiol. 52: 1-12.
194. 18F-choline images murine atherosclerotic plaques ex vivo. Arterioscler. Thromb. Vasc. Biol. 26: 584-589.
195. Liu, Y., D. Abendschein, G.E. Woodard, et al Molecular imaging of atherosclerotic plaque with (64)Cu-labeled natriuretic peptide and PET. J. Nucl. Med. 51: 85-91.
196. Lee, K.H., K.H. Jung, S.H. Song, et al 2005. Radiolabeled RGD uptake and alphav integrin expression is enhanced in ischemic murine hindlimbs. J. Nucl. Med. 46: 472-478.
197. Wu, J.C., M. Inubushi, G. Sundaresan, et al 2002. Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 106: 180-183.
198. Hofmann, M., K.C. Wollert, G.P. Meyer, et al 2005. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111: 2198-2202.
199. Falk, E., P.K. Shah & Fuster V. 1995. Coronary plaque disruption. Circulation 92: 657-671.
200. Virmani, R., A.P. Burke, A. Farb & F.D. Kolodgie 2006. Pathology of the vulnerable plaque. J. Am. Coll. Cardiol. 47: C13-C18.
201. Naghavi, M., P. Libby, E. Falk, et al 2003. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108: 1664-1672.
202. Rudd, J.H., J. Narula, H.W. Strauss, et al Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J. Am. Coll. Cardiol. 55: 2527-2535.
203. Rudd, J.H., K.S. Myers, S. Bansilal, et al 2007. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J. Am. Coll. Cardiol. 50: 892-896.
204. Tawakol, A., R.Q. Migrino, G.G. Bashian, et al 2006. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J. Am. Coll. Cardiol. 48: 1818-1824.
205. Rudd, J.H., K.S. Myers, S. Bansilal, et al 2008. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J. Nucl. Med. 49: 871-878.
206. Tahara, N., H. Kai, M. Ishibashi, et al 2006. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J. Am. Coll. Cardiol. 48: 1825-1831.
207. Wykrzykowska, J., S. Lehman, G. Williams, et al 2009. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J. Nucl. Med. 50: 563-568.